30/08/2026
There was a trial called SURMOUNT. At the end of 72 weeks, the clinical effectiveness of tirzepatide was up to 20% weight loss. For example, if someone's weight was 100 kg at the start of the trial, when your trial ended or when your scoring was noted, then your weight on an average was 20 kg in the group of tirzepatide and in the group of semaglutide, it was 13.7 kg. So this marks a significant difference between semaglutide effectiveness when it comes to controlling or managing obesity, HbA1c and other.